# Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients

> **NCT00046267** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 30 (—)

## Conditions studied

- HIV Infections
- Hypercholesterolemia
- Hypertriglyceridemia
- Diabetes Mellitus

## Interventions

- **DRUG:** Niacin

## Key facts

- **NCT ID:** NCT00046267
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2006-12
- **Final completion:** —
- **Target enrollment:** 30 (—)
- **Last updated:** 2011-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046267, "Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00046267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*